Sort by
Refine Your Search
-
Category
-
Field
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
detection of respiratory viruses and optimize pandemic response strategies? Then we are looking for you! Join our FWO-SBO project ANTICIPATE, a collaboration between the University of Antwerp, VUB and the
-
, including health economic evaluation and pandemic preparedness? Do you want to contribute to early detection of respiratory viruses and optimize pandemic response strategies? Then we are looking for you! Join
-
team of Prof. Seppe De Schepper investigates how peripheral immune signals influence brain health and disease. We focus on tissue-resident macrophages and immune cell trafficking from periphery to brain
-
well as the available public data suggest mechanisms involving genetic, epigenetic and chromatin organisation factors governing the cell-type specific response to ARS mutations. Therefore, an integrative genome-wide cis
-
life. The successful candidate will work closely with experts in food allergy, neuroimmunology, gut physiology, and computational biology to characterize immune cell responses, construct spatial maps
-
. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel insights into molecular
-
back boundaries and set a course for the future – a future that you can help to shape. The research group Energy and Materials in Infrastructure and Buildings at the Department of Building sciences in
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients